How effective are interventions to enhance adherence to psychiatric medications? Practice implications for social workers working with adults diagnosed with severe mental illness

Journal of Human Behavior in the Social Environment

Volumn 19, Issue 5, 2009, Pages 512-530

  Townsend, Lisa ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Adherence; Medication; Mental health; Mixed methods

Indexed keywords

EID: 70649088878     PISSN: 10911359     EISSN: 15403556     Source Type: Journal    
DOI: 10.1080/10911350902987987     Document Type: Article

References (61)

1. Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Upper Saddle River, NJ: Prentice-Hall.
2. Altamura, A. C., Mauri, M. (1985). Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants. British Journal of Clinical Pharmacology, 20, 714-716.
3. Ananth, J., Parameswaran, S., & Gunatilake, S. (2004). Side effects of atypical antipsy-chotic drugs. Current Pharmaceutical Design, 10(18), 2231-2238. doi: 10.2174/ 1381612043384033
4. Atkinson, J. M., Coia, D. A., Gilmour, W. H., & Harper, J. P. (1996). The impact of education groups for people with schizophrenia on social functioning and quality of life. British Journal of Psychiatry, 168, 199-204.
5. Babiker, I. E. (1986). Non-compliance in schizophrenia. Psychiatric Developments, 4,329-337.
6. Bartko, G., Varadi, H., Simon, L., Linka, E., Tuske, T., Szabo, T., & Santha, J. (2002). Patient satisfaction after switching from conventional to new atypical antipsychotics in schizophrenia. International Journal of Psychiatry in Clinical Practice, 6, 9-14. doi: 10.1080/136515002753489362
7. Bebbington, P. E. (1995). The content and context of compliance. International Clinical Psychopharmacology, 9(Suppl. 5), 41-50.
8. Breen, R. & Thornhill, J. T. (1998). Noncompliance with medication for psychiatric disorders: Reasons and remedies. CNS Drugs, 9, 457-471. doi: 10.2165/0002321 0-199809060-00004
9. Campbell Collaboration. (2005). Guidelines for preparing a review protocol. Retrieved July 15, 2005, from http://www.campbellcollaboration.org
10. Cochrane Group. (2005). The Cochrane Library: Evidence for healthcare decision-making. Retrieved July 15, 2005, from http://www.cochrane.org.
11. Cook, D. J., Greengold, N. L., Ellrodt, A. G., & Weingarten, S. R. (1997). The relation between systematic reviews and practice guidelines. Annals of Internal Medicine, 127(3), 210-216.
12. Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997). Systematic reviews: Synthesis of best evidence for clinical decisions. Annals of Internal Medicine, 126(5), 376-380.
13. Cramer, J. A., & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
14. Dolder, C. R., Lacro, J. P., Leckband, S., & Jeste, D. V. (2003). Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology, 23(4), 389-399. doi: 10.1097/01.jcp. 0000085413.08426.41
15. Eckman, T. A., Liberman, R. P., & Phipps, C. C. (1990). Teaching medication management skills to schizophrenic patients. Journal of Clinical Psychopharmacology, 10,33-38.
16. Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637-651.
17. Fishbein, M., & Ajzen, I. (1975). Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley Publishing.
18. Floersch, J. E. (2002). Meds, money, and manners: The case management of severe mental illness. New York: Columbia University Press.
19. Fortney, J., Rost, K., Zhang, M., & Pyne, J. (2001). The relationship between quality and outcome in routine depression care. Psychiatric Services, 52, 56-62. doi: 10.1176/appi.ps.52.1.56
20. Frye, M. A., Ketter, T. S., Leverich, G. S., Huggins, T., Lantz, C., Denicoff, K. D., et al. (2000). The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. Journal of Clinical Psychiatry, 61(1), 9-15.
21. Gambrill, E. (1997). Social work practice: A critical thinker's guide. New York: Oxford University Press.
22. Gray, R., Wykes, T., & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsy-chotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277-284. doi: 10.1046/j.13652850.2002.00474.x
23. Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13, 177-183.
24. Hogarty, G. E. (2002). Personal therapy for schizophrenia and related disorders: A guide to individualized treatment. New York: Guilford Press.
25. Kane, J. M. (1989), Management strategies for the treatment of schizophrenia. Journal of Clinical Psychiatry, 60(Suppl. 12), 13-17.
26. Katon, W., von Korff, M., & Lin, E. (1992). Adequacy and duration of antidepressant treatment in primary care. Medical Care, 30, 67-76.
27. Kemp, R., Hayward, P, Applewaithe, G., Everitt, B., & David, A. (1996). Compli- ance therapy in psychotic patients: Randomised controlled trial. British Medical Journal, 312, 345-349.
28. Kennedy, E., Song, F., Hunter, R., Clarke, A., & Gilbody, S. (2000). Risperidone versus typical antipsychotic medication for schizophrenia (Cochrane review). The Cochrane Library, 4.
29. Kluger, M. P., & Karras, A. (1983). Strategies for reducing missed initial appointments in a community mental health centre. Community Mental Health Journal, 19, 137-143. doi: 10.1007/BF00877606
30. Lecompte, D., & Pelc, I. (1996). A cognitive-behavioural programme to improve com- pliance with medication in patients with schizophrenia. International Journal of Mental Health, 25, 51-56.
31. Longhofer, J., Floersch, J., & Jenkins, J. H. (2003). The social grid of community medication management. American Journal of Orthopsychiatry, 73(1), 24-34. doi: 10.1037/0002-9432.73.1.24
32. MacDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions. Journal of the American Medical Association, 288(22), 2868-2879. doi: 10.1001/jama.288.22.2868
33. Macpherson, R., Jerrom, B., & Hughes, A. (1996). A controlled study of education about drug treatment in schizophrenia. British Journal of Psychiatry, 168, 709-717.
34. Maddox, J. C., Levi, M., & Thompson, C. (1994). The compliance with antidepressants in general practice. Journal of Psychopharmacology, 8, 48-53.
35. Marder, S. R. (1999). Antipsychotic drugs and relapse prevention. Schizophrenia Research, 35, S87-S92. doi: 10.1016/S0920-9964(98)00167-4
36. Melfi, C. A., Chawla, A. J., Croghan, T. W., Hanna, M.P., Kennedy, S., & Sredl, K. (1998). The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry, 55, 1128-1132. doi: 10.1001/archpsych.55.12.1128
37. Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
38. Muller-Oerlinghausen, B., Muser-Causemann, B., & Volk, J. (1992). Suicides and parasuicides in a high risk patient group on and off lithium long-term treatment. Journal of Affective Disorders, 25, 261-269. doi: 10.1016/0165-0327(92)90084-J
39. Naber, D. (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, and other clinical variables. International Clinical Psychopharmacology, 10(Suppl. 3), 133-138.
40. Nose, M., Barbui, C., Gray, R., & Tansella, M. (2003). Clinical interventions for treatment non-adherence in psychosis: A meta-analysis. British Journal of Psychiatry, 183, 197-206. doi: 10.1192/bjp.183.3.197
41. Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104-109. doi: 10.1192/bjp.180.2.104
42. Parsons, T. (1951). The social system. Glencoe, IL: Free Press.
43. Perkins, D. O. (2002). Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry, 63(12), 1121-1128.
44. Peveler, R., George, C., Kinmonth, A. L., Campbell, M., & Thompson, C. (1999). Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: Randomised controlled trial. British Medical Journal, 319, 612-615.
45. Proctor, E., & Rosen, A. (2000, May). The structure and function of social work practice guidelines. Toward the development of practice guidelines for social work intervention: A working conference. Paper presented at George Warren Brown School of Social Work, Washington University, St. Louis, MO.
46. Quraishi, S., & David, A. (2000). Depot flupenthixol decanoate for schizophrenia or similar psychotic disorders. The Cochrane Library, 4.
47. Razali, M. S., & Yahya, H. (1995). Compliance with treatment in schizophrenia: A drug intervention program in a developing country. Acta Psychiatrica Scandinavica, 91, 331-335.
48. Reamer, F. G. (2002). Ethical standards in social work: A review of the NASW code of ethics. Washington, DC: NASW Press.
49. Robinson, P., Bush, T., Von Korff, M., Katon, W., Lin, E., Simon, G. E., et al. (1995). Primary care physician use of cognitive behavioral techniques with depressed patients. Journal of Family Practice, 40, 352-357.
50. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2, 328-335.
51. Sajatovic, M., Davies, M., & Hrouda, D. R. (2004). Enhancement of treatment ad- herence among patients with bipolar disorder. Psychiatric Services, 55(3), 264-269. doi: 10.1176/appi.ps.55.3.264
52. Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi experimental designs for generalized causal inference. Boston: Houghton Mifflin.
53. Spooren, D, Van Heeringen, C., & Jannes, C. (1998). Strategies to increase compliance with out-patient aftercare among patients referred to a psychiatric emergency department: A multi-centre controlled intervention study. Psychological Medicine, 28, 949-956. doi: 10.1017/S0033291798006825
54. Thornley, B., Adams, C. E., & Awad, G. (2000). Chlorpromazine versus placebo for schizophrenia (Cochrane Review). The Cochrane Library, 4.
55. Vergouwen, A. C. M., Bakker, A., Katon, W. J., Verheij, T. J., & Koerselman, F. (2003). Improving adherence to antidepressants: A systematic review of interventions. Journal of Clinical Psychiatry, 64(12), 1415-1420.
56. Voruganti, L. N. P., & Awad, A. G. (2002). Personal evaluations of transitions in treatment (PETiT): A scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophrenia Research, 56, 37-46. doi: 10.1016/S0920- 9964(01)00161-x
57. Wahlbeck, K., Cheine, M., & Essali, M. A. (2000). Clozapine versus typical neuroleptic medication for schizophrenia (Cochrane Review). The Cochrane Library, 4.
58. Weiden, P., & Glazer, W. (1997). Assessment and treatment selection for ''revolving door'' inpatients with schizophrenia. Psychiatric Quarterly, 68, 377-392. doi: 10.1023/A:1025499131905
59. Weiden, P. J., & Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 23, 419-429.
60. Xiang, M., Ran, M., & Li, S. (1994). A controlled evaluation of psychoeducational family intervention in a rural Chinese community. British Journal of Psychiatry, 165,544-548.
61. Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to im- prove medication adherence in schizophrenia. American Journal of Psychiatry, 159(10),1653-1664. doi: 10.1176/appi.ajp.159.10.1653